Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Gains from Investment Securities (2018 - 2025)

10x Genomics (TXG) has disclosed Gains from Investment Securities for 8 consecutive years, with -$1.9 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities changed N/A to -$1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Sep 2025, up 309.09% year-over-year, with the annual reading at -$3000.0 for FY2024, 100.06% down from the prior year.
  • Gains from Investment Securities hit -$1.9 million in Q4 2025 for 10x Genomics, down from $617000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $16.6 million in Q3 2022 to a low of -$2.9 million in Q2 2022.
  • Historically, Gains from Investment Securities has averaged $2.4 million across 5 years, with a median of $736500.0 in 2025.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 165.24% in 2022 and later soared 30950.0% in 2025.
  • Year by year, Gains from Investment Securities stood at $1.7 million in 2021, then soared by 864.03% to $16.6 million in 2022, then tumbled by 97.13% to $476000.0 in 2023, then crashed by 100.42% to -$2000.0 in 2024, then plummeted by 96650.0% to -$1.9 million in 2025.
  • Business Quant data shows Gains from Investment Securities for TXG at -$1.9 million in Q4 2025, $617000.0 in Q3 2025, and $856000.0 in Q2 2025.